[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
July 1988

T4+ Cell Production of Interferon Gamma and the Clinical Spectrum of Patients at Risk for and With Acquired Immunodeficiency Syndrome

Author Affiliations

From the Division of Infectious Diseases, Cornell University Medical College, New York (Drs Murray, Kelly, and Roberts and Ms Scavuzzo), and the New York Blood Center (Dr Rubin).

Arch Intern Med. 1988;148(7):1613-1616. doi:10.1001/archinte.1988.00380070103024

• To fully characterize the relationship between the clinical manifestations of human immunodeficiency virus infection and T4+ cell defects, we determined T4+ cell number and interferon gamma (IFN-γ) production in 238 patients. For asymptomatic homosexuals, patients with acquired immunodeficiency syndrome (AIDS)-related complex (ARC), and patients with fully established AIDS, clinical status correlated linearly with both T4+ cell number and T4+ cell-derived (antigen-stimulated) IFN-γ secretion. For asymptomatic homosexuals, abnormalities In T4 + cell number and IFN-γ generation were similar irrespective of human immunodeficiency virus seropositivity. For patients with ARC, those with lymphadenopathy (LA) alone or LA plus zoster or thrombocytopenia displayed T4 + cell defects similar to those observed in asymptomatic homosexuals. Patients with ARC with LA plus constitutional symptoms and/or oral thrush, however, had fewer T4 cells, were strikingly more deficient in IFN-γ production, and closely resembled those with AIDS. Among patients with AIDS, certain individuals with Kaposi's sarcoma (KS) alone were sufficiently less cytopenic and less immunodeficient than patients with opportunistic infections (Ols) to suggest that the immune impairment that predisposes to KS may differ. At the time patients with KS developed Ols, however, T4+ cell number and IFN-γ—generating capacity had declined to the remarkably low levels observed in virtually all patients with Ols alone.

(Arch Intern Med 1988;148:1613-1616)